An open label Positron Emission Tomography (PET) study with (S,S)[18F]FMeNER-D2 to determine central norepinephrine transporter occupancy of quetiapine (SEROQUEL XRTM) in healthy male volunteers

Study identifier:D1448C00017

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An open label Positron Emission Tomography (PET) study with (S,S)[18F]FMeNER-D2 to determine central norepinephrine transporter occupancy of quetiapine (SEROQUEL XRTM) in healthy male volunteers

Medical condition

schizophrenia

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 May 2007
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria